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Abstract
The pattern recognition receptor RIG-I is critical for Type-I interferon production. However, the global regulation of RIG-I
signaling is only partially understood. Using a human genome-wide RNAi-screen, we identified 226 novel regulatory
proteins of RIG-I mediated interferon-b production. Furthermore, the screen identified a metabolic pathway that synthesizes
the inositol pyrophosphate 1-IP7 as a previously unrecognized positive regulator of interferon production. Detailed genetic
and biochemical experiments demonstrated that the kinase activities of IPPK, PPIP5K1 and PPIP5K2 (which convert IP5 to1-
IP7) were critical for both interferon induction, and the control of cellular infection by Sendai and influenza A viruses.
Conversely, ectopically expressed inositol pyrophosphate-hydrolases DIPPs attenuated interferon transcription. Mechanistic
experiments in intact cells revealed that the expression of IPPK, PPIP5K1 and PPIP5K2 was needed for the phosphorylation
and activation of IRF3, a transcription factor for interferon. The addition of purified individual inositol pyrophosphates to a
cell free reconstituted RIG-I signaling assay further identified 1-IP7 as an essential component required for IRF3 activation.
The inositol pyrophosphate may act by b-phosphoryl transfer, since its action was not recapitulated by a synthetic
phosphonoacetate analogue of 1-IP7. This study thus identified several novel regulators of RIG-I, and a new role for inositol
pyrophosphates in augmenting innate immune responses to viral infection that may have therapeutic applications.
Citation: Pulloor NK, Nair S, Kostic AD, Bist P, Weaver JD, et al. (2014) Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates
in Type-I Interferon Response. PLoS Pathog 10(2): e1003981. doi:10.1371/journal.ppat.1003981
Editor: Karen L. Mossman, McMaster University, Canada
Received August 28, 2013; Accepted January 22, 2014; Published February 27, 2014
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for
any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: MNK was funded by ASTAR and Ministry of Education. SHS was funded by NIH grant MH-18501. RL was funded by the Canadian Institutes of Health
Research grant MOP42562. AGS was funded by NIAID grant U19AI083025 and by CRIP (Center for Research on Influenza Pathogenesis), a NIAD-funded Center of
Excellence for Influenza Research and Surveillance (CEIRS, contract # HHSN266200700010C). SBS was supported by the Intramural Research Program of the NIH,
National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: manoj.krishnan@duke-nus.edu.sg
. These authors contributed equally to this work.
Introduction
The innate immune system, a primordial yet highly organized
defense mechanism, plays critical roles in the host response against
RNA viruses. The first step in the innate immune response
involves recognition of pathogen-associated molecular patterns by
several host encoded pattern recognition receptors (PRR). A key
mediator of antiviral immunity is the type-I interferon family of
cytokines, which are transcribed upon detection of RNA viruses by
the pattern recognition receptors [1–3]. Cells have developed
PRRs that are specialized for detecting pathogens in the cytosol,
the site where many RNA viruses replicate. One such PRR is the
retinoic acid inducible gene - I (RIG-I) [1–3]. RIG-I recruits the
adaptor protein MAVS to activate a signaling pathway that causes
TBK1 to phosphorylate the latent transcription factor IRF3 [4–7].
Signaling cascades triggered by multiple PRRs indeed converge to
activate IRF3. Once phosphorylated, IRF3 dimerizes and
translocates to the nucleus, where it forms a complex with the
transcriptional coactivators CBP/p300, which together stimulate
the expression of type-I interferon [1]. This initiates the antiviral
immune responses [8–10].
An optimal interferon response is essential to control viral
infections; however, excessive interferon exposure is detrimental to
the human body [11]. Significant research effort has been invested
in determining the nature of the positive and negative signaling
pathways which regulate the responses that RIG-1 elicits following
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viral infection [1,2,5,6,12–18]. Yet, there are significant gaps in
our understanding of how an appropriate interferon response is
regulated. For example, the regulation of the coupling of RIG-I
stimulation to the activation of IRF3 is not completely understood.
In particular, it has not previously been well determined if any
diffusible second messenger molecules have signaling roles in this
pathway. In addition, a comparative understanding of the
regulation of the unique RIG-I specific upstream and the
conserved (across PRRs) downstream steps of interferon produc-
tion is still lacking. In any case, the innate immune system is a
complex, multifactorial network of interconnected pathways that
exhibit combinatorial effects and emergent properties [19]; this is
an entity that is much more than the sum of its individual
components. Systems-level analysis therefore offers the most
promising approach to a comprehensive understanding of the
regulation of innate immune pathways such as the interferon
response; this information can also be exploited for the develop-
ment of novel therapeutic targets [20]. Some previous studies used
proteomics and gene expression profiling approaches to under-
stand the global regulation of innate immune response during
several RNA viral infections [21,22]. However, a systematic
interrogation of the role of all of the annotated genes of human
genome in the RIG-I signaling and interferon production is yet to
be reported.
In this study, through a systems level approach using human
genome wide RNA-interference (RNAi) screen, bioinformatics
analysis and mechanistic validations, we generated an expanded
understanding of the regulation of RIG-I mediated interferon
response. We have identified 226 novel components of the RIG-1
pathway. In particular, the approach we took in the current study
led us to identify that a class of kinases that synthesizes inositol
pyrophosphates are important positive regulators of the type-I
interferon response. The inositol pyrophosphates (also known as
diphosphoinositol polyphosphates) are a specialized subgroup of
the inositol phosphate signaling family that is distinguished by the
presence of high-energy diphosphate groups [23–25]. The inositol
pyrophosphates are known to regulate DNA damage repair [26],
apoptosis [27,28], insulin exocytosis [29], and insulin signaling
[30]. Although a role for inositol pyrophosphates in regulating
neutrophil function has also recently emerged [31], it has not
previously been reported whether they play any role in antiviral
immunity. Now, we demonstrate for the first time that the
synthesis of inositol pyrophosphates is critical for type-I interferon
transcription and antiviral immunity.
Results
Genome-Wide Screening Identifies Regulators of
RIG-I-Mediated IFNb Production
To discover novel genes regulating the RIG-I mediated
interferon response, we performed a human genome wide RNA-
interference (RNAi) screen. A quantitative fluorescence microsco-
py based assay was adopted for the screen using human interferon-
b (IFNb) promoter- driven green fluorescent protein reporter
(IFNb-GFP) (Figure 1A). The assay used human embryonic kidney
(HEK) 293 cell line, a widely used model system to dissect RIG-I
signaling [15,32,33]. As HEK293 cells do not have a robust TLR3
expression, the use of this cell line would minimize the effects from
non-RIG-I pathways [34]. As reported earlier [33], because
HEK293 cells express only moderate levels of RIG-I, transfection
of IFNb-GFP reporter along with the RIG-I ligand Polyinosinic:-
polycytidylic acid (poly (I:C)) into these cells leads to only a modest
increase in the GFP signal (Figure S1A). However, transfection of
RIG-I expression plasmid into these cells leads to a very robust
activation of GFP signal, both with and without poly (I:C)
stimulation (Figure S1A). In control experiments, silencing of RIG-
I, MAVS and IRF3, drastically reduced the RIG-I transfection
mediated IFNb-GFP signal, but there was no effect upon silencing
either TRIF (TLR3 adaptor) or MDA5 (another cytosolic PRR of
viruses) (Figure S1B). These experiments prove that the observed
reporter activity was originating specifically through RIG-I.
For the RNAi screen, we selected a condition where, 24 hr after
the transfection of a RIG-I expression plasmid (with poly (I:C)
stimulation), IFNb-GFP transcription was observed in approxi-
mately 25% of the cells. In comparison, only 1–2% of the total
cells were GFP-positive after silencing of the positive control genes
MAVS and IRF3, representing a 26.5- and 14.3-fold decrease in
IFNb-GFP reporter activity respectively (Figure S1B). High
content microscopy based imaging was used to detect and quantify
the degree of activation of the IFNb reporter. For every image, we
calculated the GFP intensity per cell (defined as a DAPI stained
nucleus), after setting an intensity threshold to identify the GFP
expressing cells. The final readout of the assay was the percent of
GFP-positive cells per well.
The screen was conducted in two stages (Figure 1A). The
primary screen involved silencing 18,120 human genes using a
pool of four unique siRNAs (from Dharmacon) targeting each
gene. Later, the ‘‘hit genes’’ from the primary screen were further
validated for on-target specificity by testing each of the four
individual siRNAs of the pool separately, and only those for which
at least two independent siRNAs impacted on reporter signal were
selected. A Z-score of (2/+) 2.5 was taken as cut-off for putative
positive or negative regulators, respectively. The analytic param-
eters for the siRNA screen including the signal intensity and
Z-score distributions are given in the Figures S2A–D. We re-
identified several previously known regulators of RIG-I pathway
such as RIG-I, IRF3, TRIM21, PRKR and MAVS as hits,
validating the ability of the screen to discover proteins that
regulate the interferon response [35,36]. More importantly, the
RNAi screen led to the identification of a total of 226 additional
Author Summary
The innate immune system is critical for viral infection
control by host organisms. The type I interferons are a
family of major antiviral cytokines produced upon the
activation of innate immune pattern recognition receptors
(PRRs) by viruses. The RIG-I is a major PRR that uniquely
detects RNA viruses within the cytoplasm. In this study, we
aimed to discover cellular genes and pathways that play
regulatory roles in the transcriptional induction of type I
interferon-b (IFNb). Using a human genome wide RNA
interference (RNAi) screening, we identified 226 genes
whose expression is important for proper IFNb production.
Through bioinformatics-based mining of the RNAi screen
results, we identified that the cellular pathway synthesiz-
ing inositol pyrophosphates, a class of inositol phosphates
with high-energy diphosphates, is a key positive regulator
of RIG-I mediated IFNb production. The kinases IPPK,
PPIP5K1 and PPIP5K2, that synthesize inositol pyrophos-
phate 1-IP7, regulated IFNb response in a catalytically
dependent manner. Mechanistic studies identified that 1-
IP7 synthesis pathway was needed for efficient phosphor-
ylation of IRF3. The DIPP family of inositol pyrophosphate
hydrolases negatively regulated the IFNb response, upon
ectopic expression. In summary, this study generated a
global view of the regulation of RIG-I signaling, and
identified inositol pyrophosphates as important regulators
of antiviral response.
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novel regulators of RIG-I mediated IFNb response (Table S1). Out
of these, 220 and 6 genes respectively were positive and negative
regulators of RIG-I signaling.
We subsequently performed detailed bioinformatics analysis to
mine the information contained within the RNAi screen results. A
meta-analysis using the Gene Expression Omnibus database
revealed that 33 of the identified RNAi hits were previously
observed as host genes upregulated upon exposure to various RNA
viruses, interferon or poly (I:C) [21,37–40] (Table S1). Network
analysis of the obtained hit genes revealed that several proteins
previously implicated to interact with components of interferon
response, but not determined yet to serve a regulatory role in
interferon response, (e.g, ADAP2 [41]) are indeed needed for
optimal interferon induction (Figure 1B). In addition, genes
serving different functions such as those regulating nuclear
transport (RAN, XPO1), ubiquitin like proteins (UBQLN2, UBL5)
and transcription (e.g., DLX3) were also among the identified hits
(Table S1). Gene ontology (GO) analysis identified several
statistically significant cellular functional categories of genes
regulating interferon production (Figure 1C). Most of the top-
ranked GO categories identified were those related to antiviral
innate immune signaling. Remarkably, gene ontology analysis also
identified the pathway involving biosynthesis of inositol pyrophos-
phates as a novel cellular process associated with interferon
response regulation (Figure 1C). Overall, our functional genomics
interrogation revealed that genes and pathways from diverse
functional categories are regulators of RIG-I mediated interferon
production.
RIG-I Regulators Act at Multiple Steps of the PRR
Signaling Cascade
In order to begin to generate a global mechanistic understand-
ing of the newly discovered regulators of IFNb response, we
attempted to place these genes in the known framework of RIG-I
signaling. It is known that ectopic expression of MAVS, TBK1
and a constitutively active mutant of IRF3 (termed IRF3-5D) can
stimulate IFNb transcription, independent of RIG-I [9,17,42]. By
coupling the ectopic expression of these genes with individual
silencing of the newly identified regulators, we generated a detailed
map of the functional localization of their action within the RIG-I
Figure 1. RNAi screening and bioinformatics analysis. (A) Screen methodology. See methods for detailed description of screening
methodology. The results of stage specific assays are shown in the brown box on the right side of panel A. Numbers and arrows shown in red and
green colour indicate steps of the primary and secondary screens, respectively. (B) Network analysis involving all ‘hits’ in the siRNA screen that have
been experimentally validated in the literature to interact with one or more components of the RIG-I pathway. Putative positive regulators of RIG-I are
indicated in green, and putative negative regulators in red. Empty circles are previously known genes of the RIG-I pathway that were not defined as
hits in our RNAi screen. (C) Gene ontology canonical pathway enrichment analysis among the novel RIG-I regulators identified in this screen. Most
enriched categories are shown. RLR, RIG-I Like Receptors. (D) Schematic showing inositol pyrophosphate synthesis pathway. IPPK, inositol 1,3,4,5,6-
pentakisphosphate 2-kinase; PPIP5K1/2, diphosphoinositol pentakisphosphate kinase 1/2; IP6K1-3, inositol hexakisphosphate kinase 1–3; IP5, inositol
pentakisphosphate; IP6, inositol hexakisphosphate; IP7, diphosphoinositol-pentakisphosphate; IP8, bisdiphosphoinositol-tetrakisphosphate.
doi:10.1371/journal.ppat.1003981.g001
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pathway. The results of the ‘‘stage determination assays’’ are
shown in Figure 1A (displayed inside the brown box) and Table
S1. Among the 226 hit genes, the greatest number (55%) was
identified to serve a regulatory role upstream of MAVS. Among
the rest, 5.5%, 11.3% and 25% of the total hit genes were found to
function between MAVS and TBK1, between TBK1 and IRF3,
and downstream of IRF3, respectively. In summary, this forward
genetics study revealed a global picture of the stage wise
distribution of 226 novel regulators of RIG-I signaling cascade.
The Inositol Pyrophosphate Biosynthesis Pathway Is
Essential for RIG-I Dependent Interferon Production
Bioinformatics analysis of the RNAi screening results identified
the kinase PPIP5K2 as a positive regulator of RIG-1 signaling
(Figure 1A, and 1B). PPIP5K2 is one of the enzymes that directly
synthesizes inositol pyrophosphates (Figure 1D). In relation to this,
IPPK is another kinase that was also identified in the screen as a
positive regulator of RIG-1 signaling; IPPK synthesizes IP6, which
serves as the common precursor material for inositol pyrophos-
phate synthesis. The key steps and enzymes involved in inositol
pyrophosphate biosynthesis are shown in Figure 1D. The best
studied inositol pyrophosphates in mammals are the two IP7
isomers (1-IP7 and 5-IP7) and IP8 [43]. These are synthesized by
two classes of enzymes, the IP6Ks and the PPIP5Ks [44–49].
The inositol pyrophosphate pathway has not previously been
implicated as participating in antiviral responses, so we set out to
further characterize its role in innate immunity. We first validated
that the siRNAs against IPPK efficiently knocked down gene
expression (Figure 2A). Moreover, Following stimulation of these
cells by transfection with RIG-I ligand poly (I:C), the knock-down
of IPPK expression was confirmed to cause a major reduction of
IFNb-promoter driven luciferase activity (Figure 2A). We also used
q-RTPCR based quantification of IFNb transcripts to verify the
role of IPPK in influencing IFNb transcript synthesis (Figure 2B).
Finally, transfection of siRNA resistant IPPK cDNA expressing
plasmid into endogenous IPPK silenced cells using 39-UTR
targeting siRNA led to the recovery of the IFNb response to a level
comparable to that in normal cells, indicating the on-target
specificity of gene silencing (Fig. S3A).
The silencing of IPPK will not only reduce the formation of IP6
but also the synthesis of the inositol pyrophosphates 1-IP7, 5-IP7
and IP8 (Figure 1D). The kinases PPIP5K1 and PPIP5K2 catalyze
the synthesis of 1-IP7 and IP8, but not 5-IP7 (Figure 1D). Indeed,
the RNAi screen also identified PPIP5K2, but not PPIP5K1, as a
RIG-1 regulator (see above). So we next investigated if the inositol
pyrophosphates play roles in innate immunity. Silencing of the
PPIP5K2 gene strongly reduced RIG-I driven IFNb transcription
and IFNb promoter driven luciferase activity (Figure 2B,C). We
also retested PPIP5K1 since it was possible that the latter was
missed in the primary screen. Notably, PPIP5K1 gene silencing
also reduced the IFNb reporter activity. Gene silencing was
verified by both Western blot (Figure 2C) and q-RTPCR (Figure
S3B). The q-RTPCR based quantification also showed a notable
decrease in the IFNb transcript production in PPIP5K2 silenced
cells (Figure 2B). As shown in Figure S3A, ectopic expression of
siRNA resistant PPIP5K2 rescued the loss of IFNb response
caused by ablation of endogenous PPIP5K2 using 39-UTR
targeting siRNA, confirming the on-target specificity of the
knockdown. The knockdown of IPPK and PPIP5Ks did not
significantly affect basal-level IFNb or IFNa production when
HEK293 cells were not stimulated by either RIG-I ectopic
expression or transfection with poly (I:C) or infection with virus
(Figure S3C, S3D). Using JAK1 silenced cells, it was further
determined that the observed effects of IPPK, PPIP5K1 and
PPIP5K2 silencing on interferon response are independent of the
autocrine amplification of the pathway (Figure S3E).
We next investigated the possible roles of the IP6Ks (IP6K1,
IP6K2 and IP6K3) which participate in the synthesis of 5-IP7 and
IP8, but not 1-IP7 Figure 1D). Although none of these genes were
identified from our genome-wide RNAi screen, we re-investigated
their role in RIG-I signaling with validation of gene silencing. It
was observed that both individual and simultaneous silencing of
IP6K1, IP6K2 and IP6K3 genes did not affect the interferon
transcription (Figure 2D). Furthermore, consistent with the gene
knockdown data, fibroblasts from IP6K1 gene deficient mouse did
not show any defect in the IFNb response (Figure S3F) [50]. The
fact that the IFNb response is inhibited by knock-down of PPIP5Ks
but not IP6Ks (Figure 2) suggests that 1-IP7, but not 5-IP7
(Figure 1D), has functional significance in the innate immune
response. Complete loss of expression of murine IP6K1 (or the
Kcs1 homologue in yeast) was previously shown to adversely affect
the functioning of mitochondria, and alters ATP levels [51].
However, no significant general cytotoxicity, mitochondrial
toxicity or change in the levels of cellular ATP was found in cells
transiently silenced for IPPK, PPIP5K1 and PPIP5K2 (Figure
S4A).
The experiments described above used poly (I:C) in order to
mimic a cellular viral infection. It is therefore significant that we
also found silencing of IPPK, PPIP5K1 and PPIP5K2 dampened
IFNb transcription during infection of HEK293 cells by Sendai
virus (SeV), a known stimulator of RIG-I [52] (Figure 2E). To
further validate the physiological relevance of IPPK, PPIP5K1 and
PPIP5K2 in IFNb production, we also silenced the expression of
these kinases in human primary monocyte derived macrophages,
and then challenged them with Sendai virus. We found a
significant decrease in IFNb transcription in these RNAi-targeted
human primary macrophages (Figure 2F). No notable difference in
SeV induced IFNb response was observed when IP6K1-3 genes
were silenced (not shown). These experiments further indicate that
the expression of the kinases involved in the synthesis of 1-IP7 is
important for an effective interferon response.
The Inositol Pyrophosphate Synthesis Pathway
Specifically Regulates the Interferon Axis from Multiple
PRRs
In addition to the transcriptional induction of IFNb, signaling
from several of the PRRs that sense RNA viruses also result in the
production of another class of type-I interferons, the IFNa, as well
as activation of the transcription factor NFkB [5]. Therefore it was
important to determine whether inositol pyrophosphate-synthesis-
pathway kinases are also required for the IFNa and NFkB response
from RIG-I. We observed that silencing of IPPK, PPIP5K1 and
PPIP5K2 in HEK293 cells led to a reduction in RIG-I mediated
transcription of IFNa, determined using a luciferase reporter
driven by the IFNa4 promoter (Figure 2G). However, inositol
pyrophosphate-synthesis-pathway kinases were not required for
RIG-I triggered NFkB activation (Figure 2H). This data indicated
that these kinases regulate a step of RIG-I signaling that happens
after the bifurcation of interferon and NFkB branches.
In addition to RIG-I, there are several other PRRs such as
TLR3 (an endosomal PRR) and MDA5 (another cytosolic PRR),
which also induce IFNb transcription [1]. Therefore we investi-
gated the specificity of the inositol pyrophosphates-synthesis-
pathway kinases with regards to signaling by other PRRs. We
found that repression of the expression of either IPPK, PPIP5K1
or PPIP5K2 attenuated the IFNb response elicited by both TLR3
and MDA5, to a level comparable to that observed in the case of
RIG-I (Figure 2I). These results demonstrated that inositol
Interferon Response and Inositol Pyrophosphates
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Figure 2. Inositol pyrophosphates pathway is needed for RIG-I mediated IFNb response. (A, C, D) Effect of silencing of IPPK, PPIP5K1, PPIP5K2,
and IP6K1-3 on p(I:C) stimulated RIG-I mediated IFNb-promoter driven luciferase reporter activity in HEK293 cells is shown. (B) Effect of silencing of IPPK,
PPIP5K1 and PPIP5K2 on poly (I:C) stimulated RIG-I mediated IFNb transcription (detected using q-RTPCR) in HEK293 cells. (E) Effect of silencing of IPPK,
PPIP5K1 and PPIP5K2 on IFNb transcription (detected using q-RTPCR) during Sendai virus infection of HEK293 cells. (F) Effect of silencing of IPPK, PPIP5K1
and PPIP5K2 in human primarymacrophages on Sendai virus induced IFNb transcription, measured by q-RTPCR. (G, H) Effect of silencing of IPPK, PPIP5K1
and PPIP5K2 on RIG-I mediated IFNa4 (G) and NFkB (H) driven luciferase reporter activities. (I) Effect of silencing of IPPK, PPIP5K1 and PPIP5K2 on IFNb
promoter reporter activity driven by activation of TLR3 (black bar) and MDA5 (red bar). The IFNb or NFkB luciferase reporter values were normalized with
Renilla luciferase reporter values, and expressed as fold change from uninduced NT-si treated samples. The mRNA level data was quantified by q-RTPCR
and expressed as fold-change, determined using the comparative Ct value based approach, using the formula 2 2 (Ct of kinase gene - Ct of b-actin), with
untreated value as 1. The statistical significance was determined by comparing the values for each gene silencing with that of corresponding stimulated
NT-si treated samples. TheWestern blot based silencing confirmation experiments for PPIP5K1 and PPIP5K2 were performed using ectopically expressed
proteins. The values are mean6 SD of one representative experiment performed in triplicates. si, siRNA; NT-si, non-targeting negative control siRNA; US,
unstimulated. GAPDH, Glyceraldehyde 3-Phosphate Dehydrogenase, cytoplasmic marker.
doi:10.1371/journal.ppat.1003981.g002
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pyrophosphates-synthesis-pathway kinases play a broader role as a
positive regulator of several major antiviral pathways.
The Inositol Pyrophosphates Synthesis Pathway is
Required for IRF3 Activation
The identification of inositol pyrophosphate-synthesis-pathway
kinases as positive regulators of the interferon response initiated by
multiple PRRs (Figure 2I) indicates that this pathway acts at or
downstream of the point in the signaling cascade where the actions
of these particular PRRs converge: activation of the kinase TBK1,
which phosphorylates IRF3, or further downstream. Indeed, the
IFNb induction arising from ectopic expression of MAVS and
TBK1, two key downstream components of RIG-I pathway, was
diminished when IPPK, PPIP5K1 and PPIP5K2 were silenced
(Figure 3A). These data further indicate that the inositol
pyrophosphates most likely regulate a step at the level or
immediately downstream of TBK1. Because activation of IRF3
happens immediately downstream of TBK1, we next investigated
the effect of interference with inositol pyrophosphate synthesis
pathway gene expression on IRF3 functioning. The IRF3 exists as
a monomer in its unstimulated state in the cytosol. When PRRs
are stimulated, the phosphorylation of monomeric IRF3 leads to
its homo-dimerization, followed by nuclear migration. We first
investigated whether inositol pyrophosphate synthesis was needed
for the nuclear translocation of activated endogenous IRF3. In
control experiments, the negative control siRNA treated HEK293
cells were stimulated with poly (I:C), which led to a prominent
nuclear accumulation of phosphorylated IRF3 (pIRF3; Figure 3B).
In additional control experiments, silencing of MAVS, the key
adaptor of RIG-I, reduced the nuclear levels of pIRF3 (Figure 3B).
Notably, there was also a major reduction in the intra-nuclear
levels of endogenous pIRF3 following silencing of IPPK, PPIP5K1
and PPIP5K2 (Figure 3B, 3C).
Next, we investigated whether the depletion of IPPK, PPIP5K1
and PPIP5K2 altered endogenous IRF3 dimerization. The
knockdown of all three of these genes strongly reduced the degree
of IRF3 dimerization that was induced by poly (I:C)(Figure 3D,E),
compared to that observed in negative control siRNA treated cells.
The levels of GAPDH and Tubulin proteins were unaffected by
the knockdown of these kinases, indicating there was not a global
perturbation of protein expression (Figures 3B, 3F).
We finally determined whether poly (I:C) induced phosphory-
lation of endogenous IRF3 was affected by silencing of inositol
pyrophosphate-synthesis-pathway kinases. Notably, it was found
that knock-down of the expression of IPPK, PPIP5K1 and
PPIP5K2 caused a reduction in the phosphorylation of endoge-
nous IRF3 (Figure 3F, 3G). In summary, the experiments
described above argue that the expression of inositol pyrophos-
phate-synthesis pathway kinases is required for the TBK1-IRF3
axis to function; the absence of inositol pyrophosphate synthesis
compromised IRF3 phosphorylation and dimer formation.
Inositol Pyrophosphate Synthesis Pathway Regulates
Interferon Response in a Catalytically Dependent Manner
Having established the involvement of the inositol pyrophos-
phate-synthesis-pathway as a regulator of antiviral response, we
further sought to identify the mechanism by which this pathway
modulates interferon signaling. We first investigated whether
enhancing the cellular expression of these kinases has any effect on
the interferon response. Indeed it was determined that the ectopic
expression of IPPK, PPIP5K1 and PPIP5K2 induced a significant
dose dependent enhancement of RIG-I driven IFNb promoter
reporter activity, in both the cells that were either stimulated or
unstimulated with poly (I:C) (Figure 4A). However, the enhancing
effect of ectopic expression of these genes on the IFNb reporter
activity in cells pre-transfected with RIG-I and poly (I:C) was
greater than that in the unstimulated cells (Figure 4A). Both
PPIP5K1 and PPIP5K2 ectopic expression caused a greater
enhancement of the IFNb response than did by IPPK. Even
though silencing of IP6Ks did not affect IFNb response, we also
investigated whether the ectopic expression of IP6K1-3 has any
effect on IFNb response. Interestingly, the ectopic expression of
IP6K1, IP6K2 and IP6K3 also enhanced the IFNb response
significantly, although to a lesser degree than that promoted by
overexpression of either PPIP5K1 or PPIP5K2 (Figure 4B). These
data revealed that the interferon response could be augmented by
over-expression of any of the tested kinases in the inositol
pyrophosphate synthesis pathway.
In order to determine whether the kinase activity of these
proteins is important for the interferon transcription, we next
transfected cells with catalytically-inactive mutants. These mutant
proteins were found to express at levels comparable to the
corresponding wild type kinases. Remarkably, the kinase deficient
mutants of IPPK, PPIP5K1 and PPIP5K2 all exhibited a
decreased ability to facilitate the interferon response upon over
expression, when compared with the corresponding wild type
proteins (Figure 4C). In addition, we noted an earlier report that
the kinase domain of PPIP5K1 (PPIP5K1-KD) and PPIP5K2
(PPIP5K2-KD) was able to catalyze the formation of 1-IP7, with
greater efficiency than the full-length protein [47]. As shown in
Figure 4D, indeed we found that over expression of both
PPIP5K1-KD and PPIP5K2-KD enhanced the IFNb reporter
activity to an extent greater than that induced by full length
PPIP5K1 and PPIP5K2. We also found that inactivation of the
catalytic activity of IP6K1 significantly diminished its ability to
enhance IFNb response upon ectopic expression (Figure 4C).
However, consistent with the gene knockdown data showing no
role for endogenous IP6Ks in RIG-I signaling, HEK293 cells
treated with IP6K kinase inhibitor TNP (N2-[m-Trifluorobenzyl],
N6-[p-nitrobenzyl] purine) did not show any defect in IFNb
response (Figure S3G) [53]. These experiments demonstrated that
the inositol pyrophosphate-synthesis-pathway kinases regulated
IFNb transcription through their catalytic activities. That is, one or
more of the soluble inositol pyrophosphates products are required
for IFNb production.
The ability of ectopically expressed PPIP5K1/2 to stimulate
interferon transcription (Figure 4A) could result from increased
synthesis of either 1-IP7 and/or IP8 (Figure 1D). For IP8 to be
involved, IP6K activity would also be required. However, the
stimulatory effects of over-expressed PPIP5K1/2 were not affected
by either individual or simultaneous silencing of IP6K1-3
(Figure 3E). Moreover, in control experiments, silencing of IPPK
nearly completely abolished the ability of ectopically expressed
PPIP5K1 and PPIP5K2 to enhance interferon transcription
(Figure 4F). That result is consistent with the requirement for
IP6 as the precursor molecule for phosphorylation by PPIP5K1/2
to synthesize 1-IP7 (Figure 1D). It was also observed that the
diminished interferon response caused by PPIP5K1 silencing
could be compensated by over expressed PPIP5K2, or vice versa
(Figure 4G). These data indicate that 1-IP7 mediates the interferon
transcriptional effects of the PPIP5K1/2.
Nevertheless, even though the aforementioned experiments
identify 1-IP7 as being more important for enhancing interferon
transcription than IP8, the ectopic expression of IP6K1, IP6K2
and IP6K3 also enhanced the IFNb response significantly
(Figure 4B). These results raise the possibility that, at elevated
IP6K1-3 expression levels, IP8 (and/or possibly even 5-IP7) might
Interferon Response and Inositol Pyrophosphates
PLOS Pathogens | www.plospathogens.org 6 February 2014 | Volume 10 | Issue 2 | e1003981
Figure 3. Inositol pyrophosphate synthesis pathway is needed for IRF3 activation. (A) Effect of silencing of IPPK, PPIP5K1 and PPIP5K2 on
IFNb promoter driven luciferase reporter activity induced by ectopic expression of RIG-I, MAVS and TBK1, in HEK293 cells. (B, C) Effect of silencing of
IPPK, PPIP5K1 and PPIP5K2 on nuclear translocation of IRF3, shown by Western blot and densitometry, respectively. (D, E) Effect of silencing of IPPK,
PPIP5K1 and PPIP5K2 on dimerization of IRF3, shown by Western blot and densitometry, respectively. (F, G) Effect of silencing of IPPK, PPIP5K1 and
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substitute for 1-IP7 in regulating IFNb expression. However,
enhanced IFNb reporter activity induced by ectopic expression of
IP6K1-3 was mostly lost in the absence of expression of PPIP5K1
and PPIP5K2 (Figure 4H). Thus, it is more likely that, at high
levels of expression of IP6K1-3, it is IP8 rather than 5-IP7 that
substitutes for the actions of 1-IP7. In this respect, it is notable that
one of the diphosphate groups on IP8 is also attached to the 1-
position.
To further establish the role of inositol pyrophosphates in the
immune response, we also studied a class of enzymes that
dephosphorylates inositol pyrophosphates. In humans, the hydro-
lysis of short-lived inositol pyrophosphates has been attributed to
three classes of diphosphoinositol-polyphosphate phosphohydro-
lase proteins (DIPPs) encoded by four genes belonging to the
Nudix hydrolase family [44,54,55]. These hydrolases remove the
terminal phosphate from inositol pyrophosphates. If inositol
pyrophosphates regulate RIG-I signaling, then removal of their
diphosphate would inhibit the interferon response. To test this
prediction, we determined the effect of over expression of DIPP1,
DIPP2a and DIPP3a on RIG-I induced IFNb promoter driven
reporter activity. In agreement with our hypothesis, cells
ectopically expressing either DIPP1, DIPP2a or DIPP3a indeed
showed a significantly attenuated interferon response (Figure 4I;
the rank order of efficacy of the DIPPs followed their reported
rank order of catalytic activity (DIPP1.DIPP3a.DIPP2a [54].
These data also further argued that the synthesis of inositol
pyrophosphates is critical for the induction of IFNb. In summary,
the experiments described in this section argue that inositol
pyrophosphates –particularly 1-IP7 - are important for the
interferon response.
1-IP7 Directly Mediates IRF3 Activation
The data described above, obtained from experiments using
gene silencing and catalytically inactive mutants of IPPK,
PPIP5K1 and PPIP5K2, provided strong yet indirect evidence
for the involvement of inositol pyrophosphates themselves in the
interferon response. To further test this hypothesis, we employed a
cell-free, virus-dependent assay for IRF3 activation. This was
developed in an earlier study which reported that a purified
mitochondrial fraction from Sendai virus infected cells could
induce IRF3 phosphorylation in a cytoplasmic fraction prepared
from uninfected cells [56]. We reproduced these results (Figure 5A)
using similar subcellular fractions (Figure S4B). It was significant
that the degree of IRF3 phosphorylation was strongly reduced
when the cytoplasmic fraction was prepared from PPIP5K2-
silenced cells (Figure 5A). Next, we reasoned that if inositol
pyrophosphates were directly involved in IRF3 phosphorylation,
their addition to the in vitro assay system would rescue the loss of
IRF3 activation caused by the silencing of PPIP5K2. For these
experiments we added samples of either 1-IP7, 5-IP7 or IP8 that
were prepared enzymatically and purified electrophoretically [57],
to the cell free IRF3 phosphorylation assays. Remarkably, 5 min
after the addition of 1-IP7 in the range of its projected
physiological concentration (0.5 uM [54]) the loss of IRF3
phosphorylation that resulted from PPIP5K2 silencing was rescued
to a level that was equivalent to that in wild type cells (Figure 5B).
At this time point, IP8 had no significant effect (Figure 5C).,
However, IP8 was found to substitute for 1-IP7 in promoting IRF3
phosphorylation, at the 10 min time point (Figure 5C,E). The
effect of 1-IP7 on IRF3 phosphorylation is consistent with the
conclusions drawn from the above described kinase silencing and
ectopic expression experiments. Next, we tested 5-IP7 which from
genetic experiments (see above) was predicted not to regulate the
interferon response. Indeed, we found that 5-IP7 did not promote
IRF3 phosphorylation (Figure 5D). The observation that IP8 acted
less efficiently than 1-IP7 in supporting IRF3 phosphorylation in
vitro, is consistent with that activity in intact cells only emerging in
an over-expression paradigm (Figure 4). In the latter case, IRF3
phosphorylation was stimulated upon ectopic expression of IP6Ks
in a manner that was also dependent upon endogenous PPIP5Ks
(Figure 4H), and hence the synthesis of IP8 (Figure 1D). In
conclusion, these cell free system based experiments considerably
strengthened our hypothesis (see above) that among the inositol
pyrophosphates, it is 1-IP7 that is the more physiologically-
relevant mediator of IRF3 phosphorylation and activation.
Earlier studies had indicated that one mechanism by which the
inositol pyrophosphates regulates signaling pathways involves the
transfer of the b-phosphoryl of their diphosphate group to
phosphorylated serine residues on target proteins (termed protein
pyrophosphorylation) [58,59]. We therefore investigated whether
the mechanism of action of inositol pyrophosphates in the
interferon response could be dependent on the transfer of their b-
phosphate. For these experiments we used synthetic analogues of
1-IP7 and IP8, in which the diphosphate was replaced with a
phosphonoacetic acid (PA) ester [60]. Although the PA ester
resembles a diphosphate group in several respects, its terminal
phosphonate group (equivalent to the b-phosphate of a diphos-
phate) cannot be transferred, due to the stability of the P-C bond
it contains. Interestingly, we found that addition of the PA
analogues of 1-IP7 and IP8 failed to recapitulate the actions of
the natural 1-IP7 and IP8 molecules (Figure 5F, 5G). These data
are consistent with potential phosphoryl transfer underlying the
mechanism of action of inositol pyrophosphates in regulating
interferon signaling.
Inositol Pyrophosphates Synthesis Pathway is Required
for Cellular Antiviral Resistance
We also investigated whether inositol pyrophosphate-synthesis-
pathway kinases contribute to the immune resistance of human
cells to viral infection. For this, we used Sendai virus to infect
HEK293 cells in which either IPPK, PPIP5K1 or PPIP5K2 was
knocked-down. In each case, the kinase knock-down led to an
increased viral load, as determined by q-RTPCR (Figure 6A).
Furthermore, we also found that HEK293 cells were more
resistant to infection with influenza A virus upon over expression
of either IPPK, PPIP5K1 or PPIP5K2 (Figures 6B and 6C).
Interestingly, ectopic expression of IP6K1 also enhanced the
cellular immunity to influenza A virus infection, in agreement with
their ability to increase the interferon response upon ectopic
PPIP5K2 on p(I:C) induced phosphorylation of IRF3, shown by Western blot and densitometry, respectively. A representative Western blot for each
experiment is shown. The IFNb-luciferase values were normalized with Renilla luciferase reporter values, and expressed as fold change from
uninduced NT-si samples. Densitometry values represent measured intensities of the indicated bands from three different Western blots, shown as
mean 6 SD. The significance of densitometry data was calculated by comparing the values obtained from gene silenced conditions with that of
stimulated NT-si controls. For panel A, the significance was determined by comparing the values of IFNb-luciferase activity obtained upon over
expression of RIG-I/MAVS/TBK1 in IPPK, PPIP5K1 and PPIP5K2 gene silenced samples with that of corresponding NT-si samples. The values are mean
6 SD of one representative experiment performed in triplicates. si, siRNA; NT-si, non-targeting negative control siRNA. GAPDH, Glyceraldehyde 3-
Phosphate Dehydrogenase, cytoplasmic marker.
doi:10.1371/journal.ppat.1003981.g003
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Figure 4. The catalytic activity of inositol pyrophosphate synthesis pathway kinases regulates IFNb response. (A, B) Ectopic expression
of inositol pyrophosphate-synthesis-pathway kinases enhanced RIG-I mediated IFNb-promoter driven luciferase reporter activity. HEK293 cells
transfected with the indicated concentrations of empty vector, or expression plasmids of (A) IPPK, PPIP5K1, and PPIP5K2, and (B) IP6K1-3, with (red
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expression (Figures 6B and 6C). We further investigated whether
interference with inositol pyrophosphate-synthesis-pathway kinas-
es can affect viral infection dependent induction of ISG15 (a major
interferon stimulated antiviral gene) in Sendai virus challenged
HEK293 cells. As shown in Figure 6D, knock-down of either
IPPK, PPIP5K1 or PPIP5K2 attenuated the induction of ISG15.
This was specifically due to a defect in interferon production or
indirect induction of ISG15 by IRF3, because the inositol
pyrophosphate-synthesis-pathway did not show any role in
exogenous IFNb induced, JAK/STAT signaling mediated ISRE
activation (not shown). Furthermore, we also found that both
p(I:C) stimulation and Sendai virus infection moderately enhanced
the transcription of IPPK, PPIP5K1 and PPIP5K2 in HEK293
cells (Figure 6E). In summary, these results further confirmed that
inositol pyrophosphate-synthesis-pathway kinases are required for
interferon mediated antiviral innate immunity.
Discussion
Our manuscript provides important new information concern-
ing the regulation of the interferon-mediated innate immune
response to infection by RNA viruses. For example, our human
genome-wide RNAi screen identified 226 novel regulators of RIG-
1 mediated IFNb transcription. A particularly significant finding of
this genomic study was the identification of the pathway
synthesizing inositol pyrophosphate 1-IP7 as being essential for
the interferon response. Moreover, this is the first time that a
specific function for 1-IP7 has been identified in mammalian cells,
thereby opening up a new area of research in the inositol
pyrophosphate field.
The importance of a genome-wide, systems-biology approach to
understanding the innate immune response was outlined in the
Introduction. Among these newly identified genes, several may be
‘‘pan-regulators’’ of interferon induction. Indeed, our secondary
assays revealed that 36.3% of the identified genes act downstream
of TBK1, a common component of several antiviral PRR
pathways. It is interesting to note that more than half (60.5%) of
the hit genes regulated a segment of the signaling chain that is
likely unique to RIG-I pathway (upstream of TBK1), and not
common with other interferon inducing PRR pathways. This
indicates that the regulation of the proximal steps of PRR signaling
leading to interferon induction is more complex than the
commonly shared steps. Given their distinct compartmentalized
cellular localizations, it is not surprising that the PRRs undergo
more intricate regulation at their proximal signaling steps, than the
downstream conserved steps.
The meta-analysis demonstrated that at least 33 of the obtained
hit genes were previously reported to show transcriptional up-
regulation during challenge with various immune stimuli that
activates interferon response. However the functional relevance of
the differential expression of these 33 genes during interferon
response was not known previously. Our identification of these
genes as important regulators of the interferon response demon-
strates that the current systems biology based approach to study
RIG-I signaling also helps to functionally interpret genomics
studies of host responses to infection. We further anticipate that
our data-set will facilitate future studies in this field. Given that
PRRs also recognize damage-associated molecular patterns
produced by endogenous stress signals [61], it is intriguing that
inositol pyrophosphates have also been implicated in mediating
responses to a variety of stress responses, including osmotic stress,
thermal challenges and metabolic stress [43]. Our study opens up
possible new directions for identifying the mechanisms of action of
inositol pyrophosphates in combating these stresses.
Our study characterized an essential regulatory role for inositol
pyrophosphates in the interferon production. Although an earlier
study had identified PPIP5K2 as an interferon inducible gene [39],
inositol pyrophosphates themselves have not been shown before to
play any direct role in antiviral innate immune response.
Structural analysis of PPIP5K2 [62] has revealed that it has an
exquisitely specific active site that can only phosphorylate IP6 and
5-IP7, to yield 1-IP7 and IP8 respectively. The in vitro reconstituted
RIG-I signaling assay using purified inositol pyrophosphates
identified that both 1-IP7 and IP8 are capable of regulating the
interferon response. However, based on the comparative analysis
of the results of experiments involving silencing of the key enzymes
in this pathway along with effects of over-expression of wild-type
kinases, we propose that 1-IP7 would most likely be the
physiologically-relevant regulator of IFNb transcription (among
inositol pyrophosphates).
The results of the virus-dependent cell free reconstitution
assays (Figure 5) provided additional direct evidence that 1-IP7 is
needed for the functioning of TBK1-IRF3 axis leading to the
phosphorylation of IRF3, a precondition for its competence to
stimulate IFNb transcription. Currently it is proposed that
inositol pyrophosphates may regulate cellular pathways either
by b-phosphoryl transfer to host proteins (protein pyropho-
sphorylation), or as cofactors that may bind to target proteins
[43,58,59,63–65]. We found that synthetic, metabolically stable
analogues of 1-IP7 and IP8 failed to recapitulate the effects of the
physiological isomers (Figure 5), consistent with a mechanism of
action involving phosphoryl transfer. Nevertheless, given that in
earlier studies [59] all of the inositol pyrophosphates were equally
competent at b-phosphoryl transfer to proteins, it is intriguing
that 5-IP7 did not support IRF3 phosphorylation, suggesting that
the potential target protein may also exhibit stereo-selective
bars) or without (black bars) p(I:C)stimulation. (C) Effect of ablation of the catalytic activity of IPPK, PPIP5K1, PPIP5K2 and IP6K1 on IFNb response. IFNb
promoter driven luciferase activity was measured in HEK293 cells ectopically expressing wild type and catalytically inactive mutants of the indicated
proteins. (D) Interferon stimulating effect of the ectopic expression of the isolated kinase domains of PPIP5K1 (PPIP5K1-KD) and PPIP5K2 (PPIP5K2-KD)
in HEK293 cells and measured by IFNb promoter driven luciferase reporter. (E) Effect of silencing of IP6K1-3 on the ability of ectopically expressed
PPIP5K1 and PPIP5K2 to enhance IFNb promoter driven luciferase activity in HEK293 cells. (F) Effect of silencing of IPPK on the ability of ectopically
expressed PPIP5K1 and PPIP5K2 to enhance IFNb promoter driven luciferase activity in HEK293 cells. (G) Effect of overexpression of PPIP5K1 or
PPIP5K2 on IFNb promoter driven luciferase activity in HEK293 cells silenced for PPIP5K2 and PPIP5K1 respectively. (H) Effect of silencing of PPIP5K1
and PPIP5K2 on the ability of ectopically expressed IP6K1-3 to enhance IFNb promoter driven luciferase activity in HEK293 cells. (I) Effect of ectopic
expression of DIPP1, and DIPP2a on RIG-I mediated IFNb promoter driven luciferase activity in HEK293 cells. RIG-I pathway activated HEK293 cells
were transfected with the indicated concentrations of the genes or empty vector, and IFNb promoter driven luciferase activity was measured. The
IFNb-luciferase values were normalized with Renilla luciferase reporter values, and expressed as fold change from empty vector transfected samples.
The significance was determined by comparing the values for each gene with that of corresponding empty vector samples. For panel G, the
significance of the recovery of IFNb-luciferase signal upon gene over expression was determined by comparing to that from kinase silenced cells. The
values are mean 6 SD of one representative experiment performed in triplicates. NT-si, non-targeting negative control siRNA; WT, wild type; DK,
kinase catalytically activity defective mutant; KD, isolated functional kinase domain only. GAPDH, Glyceraldehyde 3-Phosphate Dehydrogenase,
cytoplasmic marker.
doi:10.1371/journal.ppat.1003981.g004
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Figure 5. 1-IP7 is needed for IRF3 phosphorylation. (A) In vitro reconstituted RIG-I signaling assay reveals defect in IRF3 phosphorylation upon
the silencing of PPIP5K2. Western blot was performed at 5 and 10 minutes after mixing the uninfected cytoplasm with mitochondrial fraction from
Sendai virus (SeV) infected cells. (B–E) Effect of addition of various physiological inositol pyrophosphates on the attenuated IRF3 phosphorylation in
PPIP5K2 silenced cell extracts, determined by the in vitro reconstituted RIG-I signaling assay. Reactions were quenched at 5 or 10 min after the
addition of inositol pyrophosphates as indicated. A representative Western blot showing the effect of addition of 0.5 uM of 1-IP7 (B), IP8 (C), and 5-IP7
(D) is given. (E) Graph showing densitometry analysis of the intensity of the pIRF3 bands of the experiments shown in ‘‘B–D’’ at both 5 and 10 minute
time points. Densitometry values represent measured average intensities of the indicated bands from three different Western blots, expressed as
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recognition. It is also interesting that the phosphatidylinositol 5-
phosphate, a member of the separate inositol-lipid signaling
family, was recently reported to stimulate IRF3 phosphorylation
[66]. Thus, the distinct regulatory properties of both membrane-
restricted signals (inositol lipids) and soluble, diffusible signals
(inositol pyrophosphates), may converge upon the innate immune
response to viral invasion.
Lastly, our study may seed the discovery of novel drug targets
and drugs that can be used to manipulate the interferon response,
thereby improving therapy for viral infection. For example, it
might be possible to develop cell permeable small molecules that
are capable of imitating the role of 1-IP7. Conversely, inhibitors of
PPIP5Ks may find useful application to control excessive
interferon response observed during various medical conditions
mean 6 SD. The significance of densitometry data was calculated by comparing the values obtained from gene silenced conditions with that of
indicated negative control NT-si controls with vehicle. (F, G) Effect of addition (0.5 uM) of the synthetic phosphonoacetate analogues 1-IP7 (F) and IP8
(G) on the attenuated IRF3 phosphorylation in PPIP5K2 silenced cell extracts, determined by the in vitro reconstituted RIG-I signaling assay. Reactions
were quenched at 5 or 10 min after the addition of inositol pyrophosphates as indicated. (sa)-1-IP7, synthetic analogue of 1-IP7; (sa)-IP8, synthetic
analogue of IP8; si, siRNA; siNT, non-targeting negative control siRNA; si5K2, siRNA targeting PPIP5K2. C-siNT+M-siNT, cytoplasm of negative control
NT siRNA treated cells, mixed with mitochondria of uninfected negative control NT siRNA treated cells; C-si5K2+M-siNT/SeV, cytoplasm of PPIP5K2
siRNA treated cells, mixed with mitochondria of Sendai virus (SeV) infected negative control NT siRNA treated cells; C-siNT+M-siNT/SeV, cytoplasm of
negative control NT siRNA treated cells, mixed with mitochondria of Sendai virus (SeV) infected negative control NT siRNA treated cells. C, cytoplasm;
M, mitochondria. GAPDH, Glyceraldehyde 3-Phosphate Dehydrogenase, cytoplasmic marker.
doi:10.1371/journal.ppat.1003981.g005
Figure 6. Inositol pyrophosphates synthesis pathway is required for cellular antiviral immunity. (A) Data showing increased Sendai virus
RNA load in IPPK, PPIP5K1 and PPIP5K2 silenced HEK293 cells, measured by q-RTPCR. (B) Effect of ectopic expression of IPPK, PPIP5K1, PPIP5K2 and
IP6K1 on the infectivity of GFP-tagged influenza A virus (12 h infection assay) on HEK293 cells. Results are expressed as percentage of cells expressing
Influenza-GFP virus (from 15 images per condition), with empty vector transfected value taken as 100%. (C) Microscopic images showing effect of
ectopic expression of IPPK, PPIP5K1, PPIP5K2 and IP6K1 in HEK293 cells on influenza-GFP virus infection. A representative image is shown. (D) Effect of
silencing of IPPK, PPIP5K1 and PPIP5K2 on Sendai virus mediated induction of ISG15 protein, shown as a representative Western blot. (E) Effect of
infection with Sendai virus (SeV) or treatment with p(I:C) on the transcription of the indicated genes, measured by q-RTPCR. The mRNA level data are
expressed as fold-change, determined using the comparative Ct value based approach, using the formula 2 2 (Ct of kinase gene - Ct of b-actin), with
untreated value as 1. The significance is determined by comparing the values for each gene with that of corresponding NT-siRNA or vector controls.
The values are mean 6 SD of one representative experiment performed in triplicates. si, siRNA; NT, non-targeting negative control siRNA. GAPDH,
Glyceraldehyde 3-Phosphate Dehydrogenase, cytoplasmic marker.
doi:10.1371/journal.ppat.1003981.g006
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such as autoimmune diseases. In summary, this study provided
valuable insights into the global regulation of interferon response,
and identified a novel role for inositol pyrophosphates in antiviral
immunity.
Materials and Methods
RNA Interference Screen and Bioinformatics Analysis
The RNAi screening employed a siRNA library from
Dharmacon/ThermoFischer scientific (human whole genome
siGENOME siRNA Library, Cat#GU-005005-02) targeting
18,164 annotated human genes was used the RNAi screening.
The screen was performed in 384 well imaging compatible plates
(Corning cat#3712). Briefly, 2500 HEK293 cells (in 20 ml of
DMEM with 10% fetal bovine serum) were seeded in each well
having 50 nM siRNA complexed with 0.05 ml lipid Dharmafect1
(in 20 ml of serum free DMEM) (ThermoFischer scientific). At
46 hr, 40 ng RIG-I and 50 ng human IFNb-GFP reporter
plasmids (in 5 ml of serum free DMEM) were transfected with
Fugene (Roche). At 52 hr, 2 ml of a 10 mg/ml stock of poly (I:C)
complexed with the lipid Fugene (Roche) in serum free DMEM
was added to each well. At 72 hr, the cells were fixed with 3%
paraformaldehyde, followed by washing with phosphate buffered
saline and nuclear staining with DAPI. Using high content
fluorescence microscopy (ImageXpress Micro, Molecular Devices
Corporation), images of each well was captured at 46 magnifi-
cation. The number of cells, and number of GFP positive cells
were determined by algorithm-driven data analysis using the
MetaXpress software (Version 3, Molecular Devices Corporation).
Any gene silencing that reduced cell number by greater than
approximately 50% was eliminated for potential toxicity. siRNAs
targeting IRF3 and MAVS were used as positive controls, and a
non-targeting (NT) siRNA served as the negative control.
The bioinformatics analysis of the siRNA screen was facilitated
by the RNAither package of Bioconductor in R [67]. The screen
was performed in duplicate. The mean percent GFP-positive cells
was calculated for each gene (the screen was performed in
duplicate), and then a Z-score normalization was performed by
subtracting the median of the plate and dividing by the median
absolute deviation per plate.
Gene ontology enrichment analysis and network analysis was
conducted on the 226 novel regulators that were identified in the
secondary siRNA screen using Ingenuity Pathway Analysis (IPA)
software.
Gene Expression Meta-Analysis
Gene expression datasets were accessed from the NCBI Gene
Expression Omnibus in series matrix file format from five previous
studies [21,37–40]. Raw expression values were log2-transformed.
Two-group comparisons were made between sample sets using
Student’s t-test followed by the false-discovery rate (FDR) method
to correct for multiple hypothesis testing, setting the cut-off at
FDR,0.05. Significantly differentially expressed genes from each
study were then queried against the list of 226 genes identified
from the RNAi screen.
Reporter Assays
The reporter assays were performed as previously reported
[9,42]. Briefly, HEK293 cells were transfected with expression
plasmids of human PRRs (RIG-I or TLR3 or MDA5), human
IFNa4 promoter, or human IFNb promoter or NFkB-target
promoter driven luciferase reporters (pGL2 vector, Promega) and
a constitutively transcribed Renilla luciferase reporter (p-RL-TK,
Promega) for 24 hr. Cells were then either directly assayed for
luciferase activity, or were stimulated with poly (I:C) by either
transfecting (500 ng/ml for RIG-I assay) or by adding to the
medium (20 mg/ml for TLR3) for additional 18 hr, and luciferase
reading was performed using Dual-Glo assay kit (Promega). For
ectopic expression assays, HEK293 cells grown overnight were
transfected with the indicated plasmids for 24 hr with or without
RIG-I and poly (I:C), and luciferase assays were performed.
Values were normalized to that of Renilla luciferase internal
control.
Viral Infection and Viral Load Determination
HEK293 cells or primary macrophages were infected with
Sendai virus (Cantell strain, Charles River Laboratories) at 30–80
HA units for 18 hr, and processed for q-RTPCR. A genetically
modified Influenza A virus (IAV) (A/Puerto Rico/8/34) with
green fluorescent protein insertion was propagated in MDCK cells
and used for the studies [68]. The HEK293 cells were infected
with IAV at an MOI of 2 for 12 hr, fixed and microscopy was
performed.
IRF3 Phosphorylation, Dimerization and Nuclear
Migration Assays
The IRF3 activity was determined using previously reported
protocols [42,69,70]. Detection of IRF3 phosphorylation: Over-
night grown 56105 HEK293 cells in 6-well plates were transfected
with 500 ng of RIG-I for 24 hr, and stimulated with 4 mg of poly
(I:C) for 4 hr. The clarified cell lysate in RIPA buffer (50 mM
TrisHCl pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% NP-40, 0.1%
SDS, protease and phosphatase inhibitors) (pooled from three wells,
for each condition) were separated by Sodium dodecyl sulphate
polyacrylamide gel electrophoresis (SDS-PAGE), and probed with
anti-pIRF3 (Serine 396) and anti-IRF3 antibodies. For the detection
of IRF3 dimers, after 4 hr stimulation, the cells were lysed in mild
cold lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA
and 1%NP-40), and the protein was separated on native acrylamide
gel, with 1% sodium deoxycholate in the cathode buffer. The IRF3
dimer was visualized by Western blot. For the detection of IRF3
nuclear migration by Western blot, after 4 hr stimulation, nuclei
were isolated using Nuclear extraction Kit (Activemotif), and
cytoplasmic and nuclear proteins were separated by SDS-PAGE
and detected by Western blot. For the Western blot, the proteins
were transferred on to nitrocellulose membranes using Transblot
(Biorad), and detected by immuno-detection with appropriate
primary antibodies. The transferred proteins of interest were
visualized using Licor infrared imaging system, with IRDye
800CW and 680RD as secondary antibodies (Licor).
In Vitro Reconstituted IRF3 Phosphorylation Assay
This assay was performed as reported earlier [56]. Briefly,
cytoplasm from uninfected cells was incubated with isolated
mitochondrial fraction from Sendai virus infected cells at 30uC,
and pIRF3/IRF3 were detected by Western blot (visualized using
HRP conjugated secondary antibody) at different time points. The
assay buffer was 20 mM HEPES-KOH (pH 7.0), 2 mM ATP,
5 mM MgCl2, and 0.25 M D-mannitol.
Synthesis and Purification of 1-IP7, 5-IP7 and IP8
The methodology was reported previously [57]. The inositol
pyrophosphates were prepared enzymatically, using 1.2 mM
InsP6 as starting substrate. The synthesis of 1-InsP7, 5-InsP7
and InsP8 were carried out by incubating (at 37uC) IP6 with
respectively 0.12 mg/ml PPIP5K2KD for 22.5 h, 0.17 mg/ml
IP6K1 for 3 h or 0.17 mg/ml IP6K1 and 0.11 mg/ml
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PPIP5K2KD together for 3 h. The reaction buffer composition
was 20 mM Hepes, pH 6.8, 50 mM NaCl, 6 mM MgSO4, 1 mM
DTT, 6 mM phosphocreatine, 24 unit/ml creatine kinase and
5 mM ATP disodium salt. The reactions were quenched and
neutralized with, respectively, 0.2 volumes 2 M HClO4 and 0.34
volumes 1 M K2CO3, 40 mM EDTA or placed at 100uC for 3–
5 min. The synthesized inositol pyrophosphates were purified
using a previously reporter polyacrylamide gel electrophoresis-
based method that was modified for scale up [71]. The inositol
pyrophosphates were detected by staining with Toluidine Blue
[71], and quantified through mass assay of the released
orthophosphate upon complete hydrolysis by wet-ashing at
120uC for 48 h [72]. The phosphonoacetic acid (PA) analogues
of 1-IP7 and IP8 were chemically synthesized using a similar
strategy to that previously reported for 5-IP7 [60]. The IP8
analogue was used as a racemic mixture, i.e. a 1:1 mixture of 1,5-
[PA]2-IP4 and 3,5-[PA]2-IP4.
Gene Accession Numbers (NCBI)
IPPK, NM_022755, PPIP5K2, NM_015216; PPIP5K1,
NM_014659; IP6K1, NM_001006115; IP6K2, NM_001005911;
IP6K3, NM_054111.
Statistics
Data are expressed as mean 6 SD of one representative
experiment performed in triplicates. Statistical significance of
differences in mean values was analyzed using unpaired two-tailed
Student’s t-tests; and p-values,0.05 were be considered statisti-
cally significant. *p,0.05; **p,0.01.
Additional descriptions of the general reagents, experimental
procedures, siRNA and DNA primer sequences that were used in
the study are provided in Supplementary Methods S1.
Supporting Information
Figure S1 IFNb promoter driven GFP-based reporter
assay validation. (A) HEK293 cells were transfected with
indicated combinations of poly (I:C), IFNb promoter-GFP
reporter plasmid or RIG-I, and the percentage of GFP positive
cell were quantified at 24 h, using microscopy. Significance is
expressed by comparing to the values obtained from NO RIG-I,
NO p(I:C) samples. (B) The IFNb promoter-GFP reporter assay
specifically represents RIG-I mediated signaling. The reporter
assay was performed after silencing the indicated genes. Signifi-
cance is expressed by comparing to the values obtained from NT-
si samples. The percentage GFP positive cell values shown values
are mean 6 SD of one representative experiment performed in
triplicates.
(PDF)
Figure S2 Statistical and bioinformatics analysis of the
siRNA screen. (A) The distribution of percent GFP-positive cells
is plotted for the experimental data (grey), negative controls (red),
and positive controls (green). (B and 2C) Q-Q plots on percent
GFP-positive cells (B) and Z-score normalized values (C) support a
normal distribution. Red dots indicate negative controls and green
dots indicate positive controls. (D) The Z-score distribution is
shown with a green line indicating the cut-off for a putative
positive regulator of RIG-I (22.5) and a red line for a putative
negative regulator (+2.5).
(PDF)
Figure S3 Validation of the role of PPIP5Ks and IP6Ks
in RIG-I signaling. (A) The defect in interferon response defect
caused by silencing of the indicated genes using their 39-UTR
targeting siRNAs was rescued by complementing with corre-
sponding cDNAs. (B) siRNA treatment reduces PPIP5K1 and
PPIP5K2 transcript levels, in HEK293 cells. The mRNA levels are
expressed as fold-change, calculated using the formula 2 - (Ct of
kinase gene - Ct of b-actin), with untreated value as 1. (C) Effect of
silencing of IPPK and PPIP5Ks on basal IFNb and IFNa-promoter
driven firefly luciferase reporter activity in HEK293 cells without
RIG-I ectopic expression and p(I:C) stimulation. Data is provided
as firefly luciferase reporter activity normalized with constitutively
active Renilla luciferase activity. (D) Effect of silencing of IPPK
and PPIP5Ks on basal IFNb transcription in HEK293 cells
without RIG-I ectopic expression and p(I:C) stimulation, mea-
sured by q-RTPCR. The mRNA level data are expressed as fold-
change, determined using the comparative Ct value based
approach, using the formula 2 2 (Ct of kinase gene - Ct of b-actin),
with NT-si treated value as 1. (E) Interferon response attenuation
upon kinase knockdown is independent of autocrine amplification
of RIG-I pathway genes. JAK1 was silenced to attenuate
downstream signaling pathways leading to autocrine amplification,
and IPPK, PPIP5K1 and PPIP5K2 were simultaneously silenced,
followed by determining RIG-I driven IFNb promoter-Luciferase
reporter activity. (F) Genetic deletion of IP6K1 does not affect
IFNb promoter-Luciferase reporter activity in poly (I:C) stimulat-
ed mouse embryonic fibroblasts. (G) Treatment HEK293 cells
with IP6Ks inhibitor TNP does not affect RIG-I driven IFNb
promoter-Luciferase reporter activity. The IFNb-luciferase values
were normalized with Renilla luciferase reporter values, and
expressed as fold change from uninduced NT-si samples. The
significance is determined by comparing the values for each gene
with that of corresponding NT-si samples. The values are mean 6
SD of one representative experiment performed in triplicates.
(PDF)
Figure S4 (A) Silencing of IPPK, PPIP5K1 and PPIP5K2
does not cause toxicity. Cellular toxicity and ATP levels were
measured by using Mitochondrial ToxGlo assay (Promega). The
values are mean6 SD of one representative experiment performed
in triplicates. (B) Purity of preparations of subcellular fractions. Both
mitochondrial and cytoplasmic fractions of HEK293T cells were
separated by differential centrifugation. A representative Western
blot is shown. AIF, apoptosis inducing factor, mitochondrial
marker; GAPDH, Glyceraldehyde 3-Phosphate Dehydrogenase,
cytoplasmic marker; siNT, non-targeting negative control siRNA.
(PDF)
Table S1 226 Regulators of RIG-I mediated IFNb
production identified by RNAi screening. 226 genes that
met selection criteria are displayed in alphabetical order. Columns
F-H show the results of the ‘‘stage determination assays.’’ Column
I displays the conclusion from the ‘‘stage determination assays.’’
Columns K-N show the sequence of the individual siRNA that
gave the phenotype. The screen used four separate siRNAs against
each gene, but only those siRNAs that yielded a phenotype are
shown. Column P shows the Z-score for each gene as averaged
from duplicates. Column Q shows the results of meta-analysis in
which we investigated whether any of the hit genes had been
previously reported to undergo transcriptional upregulation by
immune stimuli. In cases where such previous reports were found,
the transcription-inducing stimulus is listed.
(XLS)
Methods S1 Additional descriptions of the general
reagents, experimental procedures, and the sequences
of the siRNA and DNA primers are provided.
(DOC)
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